chrisvoncsefalvay/vaers-outcomes huggingface dataset:
muscle pain; fatigue; dizziness (room is spinning at different degrees.); weakness; arm hurts; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (arm hurts), MYALGIA (muscle pain), FATIGUE (fatigue), DIZZINESS (dizziness (room is spinning at different degrees.)) and ASTHENIA (weakness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurts), MYALGIA (muscle pain), FATIGUE (fatigue), DIZZINESS (dizziness (room is spinning at different degrees.)) and ASTHENIA (weakness). At the time of the report, PAIN IN EXTREMITY (arm hurts), MYALGIA (muscle pain), FATIGUE (fatigue), DIZZINESS (dizziness (room is spinning at different degrees.)) and ASTHENIA (weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications listed. No treatment medications listed.   Reporter did not allow further contact
got really sick; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "they both had had COVID before" (unspecified if ongoing), notes: they both had had COVID before. The patient's concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "got really sick".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Had dizziness, poor balance, exacerbation of partial Seizure Disorder, developed Neuropathy in feet and hands. Strange sensations up and down arms, legs and fingertips.
Had vaccine 11/4/14. About 3-4 hrs afterward started having arm pain and has not resolved. Having trouble moving arm.
On the first day after my shot i had a 2 degree fever and chills starting in late morning (a bit over 24 hours after shot). The fever started dropping after 2-3 hours and was gone by evening. I?ve had no issues since.
Redness to L thigh not painful except to touch. Measured by parent 3 in x 4.5 in.
09/2/22 diagnosed with Covid.  9/12/22 noticed shortness of breath with exertion, it got worse.  Went to Dr. on 9/14/22 Diagnosed with  Post-acute COVID-19/Acute bronchitis, given albuterol inhaler and oral steroids.  10/26/22 returned to Dr. waking up in the night with cough and shortness of breath, having more episodes of shortness of breath.  I will have bloodwork on 10/31/22,  a chest x-ray tomorrow  (10/27/22) and a new inhaler.
pt recvd 1st dose of Engerix-B following 2nd Engerix-B exp pain around inject site on 19MAR92; 20MAR92 exp weakness in lt biceps;
PRURITIS, ERYTHEMA AND EDEMA 145MM X 115MM, TREATED WITH BENADRYL
Tested positive after receiving the first shot; Tested positive after receiving the first shot; This is a spontaneous report from a Pfizer-sponsored program. A consumer reported that a female patient of unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Reported stated, "They received the first dose of the COVID-19 Pfizer Vaccine and have a follow up for the second dose on the 15th which is this coming Monday and since my mother has got received the first dose she actually tested positive for COVID-19 and I am calling for her to see if I need to take her to get the second dose or how that would work like do we not need to take it or do we need to take this still. " The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Localized hive/itching around injection site. No warmth to skin. No respiratory reaction. No other reactions. Diphenhydramine 50mg oral tablets given. Medication helpful with hive/itching.  Patient stated no issues breathing or any other symptoms.
unconsolable crying, w/unusual pitch, for 6-7hr;t101.6;APAP was given by parents;
Within 24 hours of being vaccinated, the patient had a temperature of 105.5, beet red eyes, wheezing, turning blue and shaking. The ER gave her steroids and breathing treatments. The ER physician diagnosed her with vaccine induced acute bronchiolitis.
dry cough for 2 weeks; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (dry cough for 2 weeks) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (dry cough for 2 weeks). At the time of the report, COUGH (dry cough for 2 weeks) outcome was unknown.            No relevant concomitant medications reported.  No treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
10 minutes after receiving the covid vaccination patient began to feel very overheated and started to sweat profusely. Emergency services were called and took her to the nearby hospital. Around 4:30pm the same day she came back into the pharmacy to tell us they released her from the hospital but while there she experienced uncontrollable vomiting.
Initial misuse report received from a healthcare professional on 14 March 2014. A 13-month-old patient had received 0.5 ml dose of FLUZONE on an unspecified date. It was reported that the patient was administered 0.5 ml of FLUZONE. No adverse event was reported. List of documents held by sender: none
PCP gave her the flu shot on 10/12/20 at 3pm. About 3:30 that day, she felt emotional distress with anxiety, which is atypical for her. That evening around 6-7pm, she felt "off" with fatigue and the sense that something is wrong. she felt an irregular heat beat (this had happend to her one other time while healing from Covid).  She felt bronchial irritation, mild headache, brain fog, one loose stool, mild nausea. These symptoms resolved the afternoon of 10/13/20.
Broke out in hives over entire body. Passed out and throat swelled to the point of restricted breathing. Had to call 911 and spend 5 days in the ICU.
Information has been received from a physician concerning a 6 year old male with ADHD and a heart murmur and no known allergies who on 03-DEC-2007 was vaccinated with varicella virus vaccine live (Oka/Merck). Concomitant therapy included hepatitis A vaccine (inactive) (MSD) and influenza virus vaccine (unspecified). Other concomitant therapy included "methylphenidate hydrochloride". A few days after receiving the vaccines the patients mother stated that her son experienced itching all over his body. There was no product quality complaint and the patient sought unspecified medical attention. Additional information has been requested.
Post vaccination, recipient became diaphoretic. Skin cool/clammy. Denied any SOB, dyspnea or itching. Recipient reported has history of similar response to other injections. Layed recipient on the floor in a supine position with legs elevated. VS monitored. Observation TL (physician) on site. Assisted to sitting position. Escorted to observation area and monitored. Recipient remained awake, alert and conversant. Ambulatory with steady gait. Released at 1243 without incident.
Febrile reaction; erythematous rash on her left arm / localized reaction to the PPSV-23 vaccine; Inappropriate age at vaccine administration; Literature Report:.  Information was received from the authors in a published literature article entitled as stated above. This case concerns to a 23 years-old female patient. The patient's concurrent and historical conditions, as well as concomitant medications were not reported.     On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(manufacturer unknown) in the left deltoid (Lot #, expiration date, dosage, and route of administration were not provided) for prophylaxis.   On an unspecified date, one day after the vaccination, the patient presented with high grade fever, malaise and headache. The patient was admitted and the physical exam upon admission was unremarkable. Initial labs revealed leukocytosis with neutrophilia and elevated inflammatory markers. Full infections workup was pursued, including a lumbar puncture (LP) which was attempted but unsuccessful. While awaiting a radiologic guided LP, the patient experienced drastic clinical improvement with resolution of headache. As such, a repeat LP was deferred, and she was monitored clinically. The patient developed an erythematous rash on her left arm the day following admission. Due to higher suspicion for an inflammatory process, antimicrobial therapy was held. Over the next 48 hours the patient defervesced without anti-pyretic medications and the rash resolved spontaneously. The patient was treated supportively and returned to her baseline state of health within 72 hours.  The author considered the events to be related to the vaccination with pneumococcal vaccine, polyvalent (23-valent)(manufacturer unknown).  A copy of the published article has been requested.
Following vaccination, the pt fell off the exam table hitting head on floor and arms, legs and stomach were shaking (seizure) with LOC, lasting approximately 5 seconds. BP 100/70, HR 80. Ice applied, had normal neurological exam after incident, normal cardiac exam. Ice applied to face.
Room was spinning upon waking the next morning.  Once I sat up straight it stopped, but felt light headed throughout the day upon moving.    I took dramamine before bed which allowed me to lay down and symptoms subsided the following day.
This spontaneous report was received from a Registered Nurse referring to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On an unspecified date in 2016 (reported as: "One year ago"), the patient was vaccinated with the first dose of GARDASIL intramuscularly (strength, anatomical location, lot number and expiration date were not provided). On 02-MAY-2017, the patient received the second dose of GARDASIL intramuscularly (strength, anatomical location, lot number and expiration date were not provided). No adverse event was reported. Additional information has been requested.
irregular / rapid heartbeat; a-fib (irregularity)  lasted about 30 minutes.
pt recvd vax; had fever of 102.5 & cried all noc;
Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 04-APR-2022; Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 04-APR-2022; This spontaneous case was reported by an emergency medical technician and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 04-APR-2022) and EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 04-APR-2022) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022 at 4:49 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Apr-2022 at 4:49 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 04-APR-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 04-APR-2022). At the time of the report, PRODUCT STORAGE ERROR (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 04-APR-2022) and EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021 and administered on 04-APR-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
pt recvd vax & on 10AGU92 exp drug induced hepatitis (non-infectious) which is thought to be due to Hep B vax; out of work 14 days; has returned to work;
he was excited and/or anxious about getting vax after having Covid in November. vax dose approx 305 pm, by 310 he reported feeling weak with rapid pulse and heart fluttering. Gave water to drink, he declined food. 315 he felt hot sweaty and took off his overcoat. 325 said he felt better after drinking the water and declined to have his bp or pulse checked. Follow up phone call 3/14 to check on condition, said he felt ok after leaving pharmacy and has no allergies, no current illnesses and no vaccines within past month.
Redness, swelling of arm after injection, swollen for about 1 wk before resolving. (right arm where pneumovax was given).
Patient had rash begin the same day which led to larger rash that was not treated. Patient was seen at Medical Center more than once and then was transferred for higher level of care due to skin condition from Medical Center.
Moderna Monovalent given 5/2/23 instead f bivalent. No adverse effects or symptoms reported by caregiver.
swelling from his shoulder to his hand; He had pain, redness, and swelling in right arm; had pain, redness, and swelling in right arm; This spontaneous report was received from a certified nursing assistant and refers to a 72 year old male patient. The patient's pertinent medical history was not provided. The patient's historical drugs included simvastatin (ZOCOR) which caused drug allergy (MARRS # 2010USA002785). The patient concurrent conditions included hypertension, Prediabetes, high cholesterol, enlarged prostate and acid reflux. The patient's concomitant therapies included tamsulosin hydrochloride, metformin hydrochloride (GLUCOPHAGE), lisinopril(manufacturer unknown), omeprazole and fluticasone propionate(FLONASE).   On 06-OCT-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) 0.5 mililier, intramuscular lot # T009744, expiration date on 28-JAN-2022 (anatomical location was not provided) for prevention of pneumonia. On the same date, the patient experienced swelling from his right shoulder to his hand (peripheral swelling), right arm pain (pain in extremity) and right arm redness (erythema). The patient did not seek medical attention, however medical treatment with ibuprofen was given to the patient for the events.  The outcome of peripheral swelling was not resolved (reported as the patient still had some swelling). The outcome of pain in extremity and erythema was unknown. The causality between the events and therapy with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) was not provided. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T009744; expirationdate: 28-JAN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent; Sender's Comments:  US-009507513-2010USA002785:
Information has been received from a physician concerning a 14 year old female patient with no medical history and no drug reaction or allergy who on 22-FEB-2011 and 08-JUL-2011 was vaccinated with the first dose of GARDASIL (lot number: 666595/0096Z; Expiration date: 12-OCT-2014) and the second dose of GARDASIL (lot number: 669308/0636AA; Expiration date: 11-AUG-2013) respectively. There was no concomitant medication. On 09-JUL-2011 the patient complained of abdominal pain, nausea and decreased appetite after receiving the second dose of GARDASIL. The patient did not have any problem with the first dose. The patient saw the physician and was given PRILOSEC for treatment. Gastrointestinal (GI) test and blood work were performed without results. At the time of the report, the patient had not recovered. Follow-up information has been received from the physician concerning the female patient. The patient had no illness at time of vaccination. The patient received the second dose of GARDASIL (lot number: 669308/0636AA) in left arm (route not reported). One day post the second dose, on 09-JUL-2011 the patient had nausea and abdominal pain. She did not improve on PRILOSEC. Cholecystokinin (CCK) test/ Hepatobiliary Imino-Diacetic Acid (HIDA) scan of abdomen showed non-functioning gallbladder. The patient had laparotomy (LAP) and cholecystectomy on 15-SEP-2011 with complete recovery. Upon internal review, non-functioning gallbladder required laparotomy and cholecystectomy was considered to be an other important medical event. Additional information has been requested.
friend came down with COVID; friend came down with COVID; This is a spontaneous report from a contactable consumer (reporting for friend). A 86-year old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot number and expiration date not reported) (at the age of 86-years-old), via an unspecified route of administration on 14Jan2021 as a single dose for covid-19 immunization.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient reported that on 21Jan2021 she "came down with COVID."  The clinical outcome of the events COVID was unknown.    The batch/lot number for the vaccine, BNT162B2, was not provided and information about lot/batch number cannot be obtained. .No follow up attempts are possible.
Around midnight, the night of the shot, started with Fever, Chills, Headache, Fatigue, Nausia.  This continued for an entire day.  Since this was the first dose, I'm curious to know if I should even get the second dose.??  I did have COVID back in Nov/Dec. 2020.
A Red Dot Where Needle was Injected a 3 inch red circle around the dot. Not Hot. Not Sore
Child awoke after nap on 9/13 with fever/felt warm to touch and immediately began having seizure. 911 called, child transported to hospital. Full workup for infection done-- no infection or other signs of illness found.
Temp 106, after receiving DTP immunization reported to MD.  The next day child's temp 103 and controlled with tylenol.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Apr2021 at 08:00 as dose 1, single, in left arm, on 26Apr2021 at 08:00 as dose 2, single, in left arm and on 03Jan2022 at 08:00 as dose 3 (booster), single at the age of 38 years, in left arm for covid-19 immunization. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ARMODAFINIL, start date: 05Aug2015; LAMOTRIGINE, start date: 17Sep2021; PROZAC, start date: 07Feb2006; WELLBUTRIN, start date: 06Feb2006.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical information: The patient had no known allergies and other medical history of Asthma.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Diffuse pruritic rash beginning on DAY 6 post vaccine on chest/abdomen/back/legs/arms/sides of feet/wrists. Saw urgent care prescribed steroids, Benadryl, Vistaril, Zyrtec; also using Benadryl OTC cream Symptoms of pruritic  so severe difficulty with working and sleeping  Rash and itching is persistent
injection site pain Narrative:  SWOLLEN GLANDS, ARM PAIN AND  SWELLING  Other Relevant History:
Swelling at injection site, hot, red and hives, stiffness all muscles, tired, light headache, swelling and pain in arm injected for 5 days.  Had to take TYLENOL to be able to work very tired.
I received the Moderna Covid-19 Vaccine 02/04/21. On 02/05/21 I woke up with off and on chills/sweats, body aches, nausea, and headache. This lasted until 8PM on 02/05/21
FLU SYMPTOMS; HAIR FALLING OUT / HAIR THINNING; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19. The patient was previously treated with calcium chloride/glucose/magnesium chloride/potassium chloride/sodium chloride/sodium lactate. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The Batch number was not reported and has been requested. No concomitant medications were reported.  On MAR-2021, the subject experienced flu symptoms. On MAR-2021, the subject experienced hair falling out / hair thinning. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the flu symptoms and hair falling out / hair thinning was not reported. This report was non-serious.
December 1, 2021 I got the Pfizer booster.  Got a headache three hours after.  12/2 was achy, tired.  On 12/3 woke up with an egg shaped mass under my arm and itchy feeling at that site.  12/4 broke out with a rash with welts going down my left side.  12/5 rash with welts moved to my back at shoulder area.  12/6 rash was in same areas as prior days + moved to private areas.  12/7  rash with welts were also on lower back.  Rash with welts have been on my elbows, hands, forearms , legs, feet including itching on the bottoms of my feet.  Right eye itched for maybe 3 days.  Palms of my hands also.  Moved to the right side of my body down my side and under my bra line.  This continued for all of December.  Towards the end of the month the rash was in smaller areas on my body.  it would just come up at any given point of the day.  The egg shaped mass lasted 5 days and went down.  I have documented some of the days with pictures on my cell phone.  I contacted my Dr. was told to take allergy medication.  I used Caladryl on the sites as well.  This is January 1st and I still have small flair ups.  Not as severe as the first 3 weeks after the booster.  Going forward, my question is, if another booster is needed in the future should I get a booster?  I have asthma and other upper respiratory issues.